Close menu




 

Armin Schulz

  • IT
  • Trading
  • Technology

Born in Mönchengladbach, he studied business administration in the Netherlands. In the course of his studies he came into contact with the stock exchange for the first time. He has more than 25 years of experience in stock market business.

After graduating, he worked as an IT consultant for a listed company before becoming self-employed, during which time he worked for various DAX-listed companies and a large Swiss insurance company, among others.
Since 2009, he has been exclusively involved in the capital markets, where he was able to gain experience as a day and swing trader, in investor relations and at board level. He was able to live out his passion for numbers in the controlling department of a securities trading house.

For him, fundamental analysis paired with the correct reading of the price action of a market provides the basis for successful trading.


Commented by Armin Schulz

Commented by Armin Schulz on September 2nd, 2025 | 07:25 CEST

After the price corrections: Is now the time for Novo Nordisk, Almonty Industries, and Puma?

  • Mining
  • Tungsten
  • Defense
  • Biotechnology
  • Sportswear

Volatile periods offer the greatest opportunities for savvy investors. While the masses are unsettled by price fluctuations, strategic investors have the chance to acquire fundamentally sound stocks at attractive prices. This discipline of keeping calm in the face of uncertainty separates the long-term winners from the losers. Three companies currently deserving of precisely this attention are Novo Nordisk, Almonty Industries, and Puma.

Read

Commented by Armin Schulz on September 1st, 2025 | 07:10 CEST

The hidden opportunity: Why Commerzbank, Desert Gold, and K+S are now in focus

  • Mining
  • Gold
  • Commodities
  • Banking
  • Investments
  • fertilizer

The stock markets resemble a minefield: geopolitical tensions, unpredictable interest rate policies, and protectionist trade measures create an explosive mixture. In this environment, making informed investment decisions is crucial for protecting and growing capital. While safe havens are booming, cyclical stocks are struggling with the uncertainties. Against this backdrop, it is worthwhile to take a closer look at the strategic positioning of Commerzbank, the potential of gold explorer Desert Gold, and the resilience of fertilizer specialist K+S.

Read

Commented by Armin Schulz on August 28th, 2025 | 07:15 CEST

The BioNxt Solutions formula: How a simple idea can turn into a billion-dollar business – Without high risk

  • Biotechnology
  • Biotech

In the pharmaceutical industry, promising active ingredients often fail due to a simple problem, such as administration. Canadian biotech company BioNxt Solutions has taken on precisely this challenge. With a smart platform for oral dissolvable films and patches, the Vancouver-based innovator could not only make life easier for patients but also open up a lucrative growth opportunity for investors. We took a closer look at the promising technology behind it.

Read

Commented by Armin Schulz on August 28th, 2025 | 07:00 CEST

The silver boom: What investors need to know about Intel, Silver North Resources, and Xiaomi

  • Mining
  • Silver
  • Commodities
  • Technology
  • consumergoods

Silver is experiencing a historic surge, driven by the megatrends of our time. Industrial demand is exploding, fueled by the tech revolution, the green energy transition, and the electrification of our everyday lives. This indispensable commodity, the best electrical conductor, is found in every smartphone, every electric vehicle, and every solar cell. Supply can barely keep up. Today, we are examining two electronics companies that face high silver prices and analyzing a silver company that is in an exciting phase.

Read

Commented by Armin Schulz on August 27th, 2025 | 07:15 CEST

Benefit from the hydrogen boom: The most promising developments at Nel ASA, dynaCERT, and Daimler Truck

  • Hydrogen
  • GreenTech
  • greenhydrogen
  • Trucks

The hydrogen market is booming! A groundbreaking efficiency record in electrolysis is revolutionizing production costs. At the same time, the world's first commercial hydrogen flight connection is launching, proving the technology's suitability for everyday use. This boom is confirmed by a European hydrogen auction, which underscores the immense competitiveness of green hydrogen with record results. These three powerful impulses are now also driving the established players. The developments at Nel ASA, dynaCERT, and Daimler Truck are particularly noteworthy.

Read

Commented by Armin Schulz on August 27th, 2025 | 07:05 CEST

China's leverage: Why Rheinmetall is struggling, European Lithium is benefiting, and BYD remains confident

  • Mining
  • Lithium
  • RareEarths
  • Defense
  • Electromobility

The next wave of global conflicts will not be fought with weapons, but with export licenses. At the heart of this geopolitical struggle are critical metals without which no high-tech weapon, electric vehicle, or wind turbine can function. China's recent tightening of export restrictions has exposed the West's brutal dependency, forcing governments and corporations alike to rapidly rethink and realign their supply chains. While some companies are fighting to secure their supply chains, others are consolidating their sources or celebrating their monopolistic position. Three companies exemplify this dichotomy: the recently pressured defense giant Rheinmetall, the rare earth and lithium beneficiary European Lithium, and the Chinese giant BYD.

Read

Commented by Armin Schulz on August 26th, 2025 | 07:10 CEST

The blueprint for AI-driven drug discovery: How Evotec, NetraMark Holdings, and BioNTech are leveraging new opportunities

  • Biotechnology
  • Biotech
  • AI
  • Pharma

The pharmaceutical industry is undergoing a revolution. Artificial intelligence is reducing drug discovery times from years to months and dramatically increasing hit rates. Data-driven predictions and virtual simulations are increasingly replacing costly trial-and-error approaches. This technological leap is already generating concrete successes and massive competitive advantages for pioneers who implemented their digitalization strategies early on. Most recently, an AI-designed drug advanced to clinical trials in record time. Three companies driving this change and reaping its benefits are Evotec, NetraMark Holdings, and BioNTech.

Read

Commented by Armin Schulz on August 25th, 2025 | 07:30 CEST

Defense, tungsten, algorithms: Invest in market leaders Rheinmetall, Almonty Industries, and Palantir

  • Mining
  • Tungsten
  • Defense
  • Software
  • hightech

In a world undergoing geopolitical upheaval, three key sectors are coming into focus: modern defense technology, critical raw materials, and strategic data analysis. While defense giants are benefiting from rising military budgets, raw material pioneers are satisfying the hunger for materials in the high-tech and defense industries. At the same time, data analysis is monetizing this new complexity for both companies and government security agencies. The successful convergence of these sectors is creating unique growth opportunities. Anyone looking to invest in the defense and security sector should keep an eye on market leaders Rheinmetall, Almonty Industries, and Palantir. They benefit from stability, innovative strength, and reliable growth opportunities.

Read

Commented by Armin Schulz on August 21st, 2025 | 07:10 CEST

Overvaluations in pharma and biotech reduced – Novo Nordisk, BioNxt Solutions, and Bayer are NOW in focus

  • Biotechnology
  • Biotech
  • Pharma

Following the drastic market correction since the waning of the COVID-19 pandemic, the pharma and biotech sectors now offer more rationalized valuations and real opportunities. Instead of speculative hype, solid pipelines, clinical results, and disruptive technologies are what count today. Artificial intelligence is revolutionizing drug development, accelerating processes, and creating measurable competitive advantages. This new reality makes companies that are mastering their digital transformation particularly promising candidates. However, it is important to take a close look at each company. That is why we are examining three exciting companies today where there is a lot going on: Novo Nordisk, BioNxt Solutions, and Bayer.

Read

Commented by Armin Schulz on August 19th, 2025 | 07:15 CEST

TUI, naoo, Puma – Three stocks whose digital revolution could double your portfolio

  • AI
  • Digitization
  • Technology
  • travel
  • Sportswear

If you are not thinking digitally today, you are losing out. Period. Progressive companies do not just use AI and data; they link them to their core business. The result? Less friction, more room for growth, and customers who come back. These companies are not only leaving the competition behind, but they are also becoming magnets for savvy investors. Let's take a closer look at how TUI, naoo, and Puma are intelligently using their data, AI, and platforms to make their businesses fit for the future.

Read